The focus of the group will be to improve health outcomes as well as economic growth on the international stage by leveraging Finn Partners’ considerable resources and marketing capabilities.
The unit will be led by MD Cynthia Isaac, alongside head of reputation and risk management Miriam Kalnicki and head of corporate and biotech media Christopher Hippolyte.